Sigmund Brabrand
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Health-related Quality of Life Outcomes of Salvage Metastasis-directed Treatment Versus Elective Nodal Treatment for Oligorecurrent Nodal Prostate Cancer: A Secondary Analysis of the Phase 2, Open-label PEACE V-STORM Randomized Trial.
Journal: European urology oncology
Published: December 12, 2025
Health-related Quality of Life Outcomes of Salvage Metastasis-directed Treatment Versus Elective Nodal Treatment for Oligorecurrent Nodal Prostate Cancer: A Secondary Analysis of the Phase 2, Open-label PEACE V-STORM Randomized Trial.
Journal: European urology oncology
Published: December 12, 2025
Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trial.
Journal: Acta oncologica (Stockholm, Sweden)
Published: November 26, 2025
Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V-STORM): a phase 2, open-label, randomised controlled trial.
Journal: The Lancet. Oncology
Published: February 11, 2025
Raising the quality of cancer treatment
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke
Published: January 23, 2024
IMPRESS-Norway: improving public cancer care by implementing precision medicine in Norway; inclusion rates and preliminary results.
Journal: Acta oncologica (Stockholm, Sweden)
Published: December 21, 2023
PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial.
Journal: European urology oncology
Published: May 17, 2023
Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway.
Journal: Journal of translational medicine
Published: July 15, 2022
Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway.
Journal: Journal of translational medicine
Published: March 17, 2022
Ten-year survival after High-Dose-Rate Brachytherapy combined with External Beam Radiation Therapy in high-risk prostate cancer: A comparison with the Norwegian SPCG-7 cohort.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: June 04, 2018
Exome sequencing of bilateral testicular germ cell tumors suggests independent development lineages.
Exome sequencing of bilateral testicular germ cell tumors suggests independent development lineages.
Journal: Neoplasia (New York, N.Y.)
Published: December 04, 2014
Probability of metachronous testicular cancer in patients with biopsy-proven intratubular germ cell neoplasia depends on first-time treatment of germ cell cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 17, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026